Vanessa Elharrar

9.8k total citations
16 papers, 640 citations indexed

About

Vanessa Elharrar is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Vanessa Elharrar has authored 16 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Vanessa Elharrar's work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (10 papers) and HIV Research and Treatment (5 papers). Vanessa Elharrar is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (10 papers) and HIV Research and Treatment (5 papers). Vanessa Elharrar collaborates with scholars based in United States, South Africa and Zambia. Vanessa Elharrar's co-authors include Linda‐Gail Bekker, Robert M. Grant, Bonnie J. Dye, Surita Roux, K. Rivet Amico, Kenneth H. Mayer, Vanessa Cummings, Susan H. Eshleman, Estelle Piwowar‐Manning and Melissa Wallace and has published in prestigious journals such as PLoS ONE, JAMA Internal Medicine and AIDS and Behavior.

In The Last Decade

Vanessa Elharrar

14 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Elharrar United States 11 575 397 299 148 94 16 640
Jennifer Brothers United States 10 654 1.1× 426 1.1× 281 0.9× 204 1.4× 83 0.9× 14 699
Geetha Beauchamp United States 18 689 1.2× 567 1.4× 246 0.8× 160 1.1× 159 1.7× 39 814
Bonnie J. Dye United States 11 383 0.7× 278 0.7× 232 0.8× 158 1.1× 45 0.5× 17 509
Elizabeth Pembleton United States 8 791 1.4× 639 1.6× 339 1.1× 282 1.9× 72 0.8× 8 910
Afiachukwu Onuegbu United States 3 778 1.4× 513 1.3× 401 1.3× 126 0.9× 140 1.5× 10 878
Brandon O’Hara United States 8 511 0.9× 403 1.0× 183 0.6× 184 1.2× 94 1.0× 9 643
J. Stan Lehman United States 14 489 0.9× 452 1.1× 323 1.1× 187 1.3× 101 1.1× 20 689
Cathy Maulsby United States 13 629 1.1× 481 1.2× 299 1.0× 180 1.2× 77 0.8× 23 698
Wendy Garland United States 12 502 0.9× 323 0.8× 229 0.8× 77 0.5× 106 1.1× 22 593
Murugi Micheni United States 13 385 0.7× 271 0.7× 194 0.6× 135 0.9× 49 0.5× 23 482

Countries citing papers authored by Vanessa Elharrar

Since Specialization
Citations

This map shows the geographic impact of Vanessa Elharrar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Elharrar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Elharrar more than expected).

Fields of papers citing papers by Vanessa Elharrar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Elharrar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Elharrar. The network helps show where Vanessa Elharrar may publish in the future.

Co-authorship network of co-authors of Vanessa Elharrar

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Elharrar. A scholar is included among the top collaborators of Vanessa Elharrar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Elharrar. Vanessa Elharrar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Elharrar, Vanessa, Sharon A. Riddler, Edward Livant, et al.. (2024). Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015. UNC Libraries.
2.
Bekker, Linda‐Gail, Surita Roux, K. Rivet Amico, et al.. (2017). Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. The Lancet HIV. 5(2). e68–e78. 89 indexed citations
3.
Riddler, Sharon A., Marla Husnik, Gita Ramjee, et al.. (2017). HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial. PLoS ONE. 12(6). e0178594–e0178594. 3 indexed citations
4.
El‐Sadr, Wafaa, Deborah Donnell, Geetha Beauchamp, et al.. (2017). Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients. JAMA Internal Medicine. 177(8). 1083–1083. 106 indexed citations
5.
Riddler, Sharon A., Marla Husnik, Pamina M. Gorbach, et al.. (2016). Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015. HIV Clinical Trials. 17(5). 204–211. 5 indexed citations
6.
Amico, K. Rivet, Melissa Wallace, Linda‐Gail Bekker, et al.. (2016). Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and Behavior. 21(5). 1361–1375. 115 indexed citations
7.
Safren, Steven A., James P. Hughes, Matthew J. Mimiaga, et al.. (2016). Frequency and predictors of estimated HIV transmissions and bacterial STI acquisition among HIV‐positive patients in HIV care across three continents. Journal of the International AIDS Society. 19(1). 21096–21096. 13 indexed citations
8.
Magidson, Jessica F., Xin Li, Matthew J. Mimiaga, et al.. (2015). Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings. AIDS and Behavior. 20(4). 699–709. 27 indexed citations
9.
Tieu, Hong‐Van, Ting‐Yuan Liu, Sophia A. Hussen, et al.. (2015). Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities. PLoS ONE. 10(8). e0134085–e0134085. 48 indexed citations
10.
Closson, Elizabeth F., Matthew J. Mimiaga, Susan G. Sherman, et al.. (2015). Intimacy versus Isolation: A Qualitative Study of Sexual Practices among Sexually Active HIV-Infected Patients in HIV Care in Brazil, Thailand, and Zambia. PLoS ONE. 10(3). e0120957–e0120957. 19 indexed citations
11.
Riddler, Sharon A., Marla Husnik, Arendevi Pather, et al.. (2014). Long-term Follow-up of HIV Seroconverters from the VOICE Trial - An Analysis of Data from MTN-015. AIDS Research and Human Retroviruses. 30(S1). A93–A93.
12.
Gwadz, Marya, Charles M. Cleland, Amanda S. Ritchie, et al.. (2014). ACT2 Peer-Driven Intervention Increases Enrollment into HIV/AIDS Medical Studies Among African Americans/Blacks and Hispanics: A Cluster Randomized Controlled Trial. AIDS and Behavior. 18(12). 2409–2422. 18 indexed citations
13.
Burns, David, Cynthia Grossman, Jim A. Turpin, Vanessa Elharrar, & Fulvia Veronese. (2014). Role of Oral Pre-exposure Prophylaxis (PrEP) in Current and Future HIV Prevention Strategies. Current HIV/AIDS Reports. 11(4). 393–403. 23 indexed citations
14.
Шаболтас, Алла Вадимовна, et al.. (2014). The Feasibility of an Intensive Case Management Program for Injection Drug Users on Antiretroviral Therapy in St. Petersburg, Russia. SSRN Electronic Journal. 1 indexed citations
15.
Koblin, Beryl A., Kenneth H. Mayer, Susan H. Eshleman, et al.. (2013). Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061. PLoS ONE. 8(7). e70413–e70413. 161 indexed citations
16.
Шаболтас, Алла Вадимовна, et al.. (2013). The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia. Harm Reduction Journal. 10(1). 15–15. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Brothers Breakdown of academic impact, for papers by Geetha Beauchamp Breakdown of academic impact, for papers by Bonnie J. Dye Breakdown of academic impact, for papers by Elizabeth Pembleton Breakdown of academic impact, for papers by Afiachukwu Onuegbu Breakdown of academic impact, for papers by Brandon O’Hara Breakdown of academic impact, for papers by J. Stan Lehman Breakdown of academic impact, for papers by Cathy Maulsby Breakdown of academic impact, for papers by Wendy Garland Breakdown of academic impact, for papers by Murugi Micheni
Rankless by CCL
2026